Influence of mitochondrial DNA 5178 C/A polymorphism on serum cholesterol changes: a short-term follow-up in middle-aged Japanese men

Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet. 1998;351(9097):185–6. Tanaka M, Gong J, Zhang J, Yamada Y, Borgeld HJ, Yagi K. Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mech Ageing Dev. 2000;116(2–3):65–76. Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987;325(6099):31–6. Yao YG, Kong QP, Zhang YP. Mitochondrial DNA 5178A polymorphism and longevity. Hum Genet. 2002;111(4–5):462–3. Shimokata H, Yamada Y, Nakagawa M, Okubo R, Saido T, Funakoshi A, et al. Distribution of geriatric disease-related genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol. 2000;10[Suppl 1]:S46–55. Wang D, Taniyama M, Suzuki Y, Katagiri T, Ban Y. Association of the mitochondrial DNA 5178A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients. Exp Clin Endocrinol Diabetes. 2001;109(7):361–4. Matsunaga H, Tanaka Y, Tanaka M, Gong JS, Zhang J, Nomiyama T, et al. Antiatherogenic mitochondrial genotype in patients with type 2 diabetes. Diabetes Care. 2001;24(3):500–3. Mukae S, Aoki S, Itoh S, Sato R, Nishio K, Iwata T, et al. Mitochondrial 5178A/C genotype is associated with acute myocardial infarction. Circ J. 2003;67(1):16–20. Ohkubo R, Nakagawa M, Ikeda K, Kodama T, Arimura K, Akiba S, et al. Cerebrovascular disorders and genetic polymorphisms: mitochondrial DNA5178C is predominant in cerebrovascular disorders. J Neurol Sci. 2002;198(1–2):31–5. Aoyama M, Shidoji Y, Saimei M, Tsunawake N, Ichinose M. Phenotypic linkage between single-nucleotide polymorphisms of beta3-adrenergic receptor gene and NADH dehydrogenase subunit-2 gene, with special reference to eating behavior. Biochem Biophys Res Commun. 2003;309(1):261–5. Kato T, Kunugi H, Nanko S, Kato N. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. Am J Med Genet. 2000;96(2):182–6. Iwao N, Iwao S, Kobayashi F, Tajima K, Tanaka M, Atsuta Y, et al. No association of the mitochondrial genotype (Mt5178A/C) with six cancers in a Japanese population. Asian Pac J Cancer Prev. 2003;4(4):331–6. Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Sekine Y, Teruya K, et al. Association of the mitochondrial DNA 5178 A/C polymorphism with serum lipid levels in the Japanese population. Hum Genet. 2001;109(5):521–5. Takagi K, Yamada Y, Gong JS, Sone T, Yokota M, Tanaka M. Association of a 5178C-->A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals. Atherosclerosis. 2004;175(2):281–6. Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Sekine Y, Sekiguchi K, et al. Longevity-associated mitochondrial DNA 5178 A/C polymorphism modulates effects of daily drinking and cigarette consumption on serum triglyceride levels in middle-aged Japanese men. Exp Gerontol. 2003;38(10):1071–6. Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Makita R, Satoh M, et al. Overview of longevity-associated mitochondrial DNA 5178 C/A polymorphism and a discussion of its modulation of the effects of habitual smoking on serum total and LDL cholesterol levels in middle-aged Japanese men. In: Woods CR, editor. Trends in DNA research. New York: Nova Science; 2006. p. 33–51. Murata K, Yano E. Medical statistics for evidence-based medicine with SPBS user’s guide. Tokyo: Nankodo Publisher; 2002. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49(6):M252–7. Wallace RB, Colsher PL. Blood lipid distributions in older persons. Prevalence and correlates of hyperlipidemia. Ann Epidemiol. 1992;2(1–2):15–21. Frishman WH, Ooi WL, Derman MP, Eder HA, Gidez LI, Ben-Zeev D, et al. Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol. 1992;2(1–2):43–50. Rahilly-Tierney C, Bowman TS, Djoussé L, Sesso HD, Gaziano JM. Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians. Am J Cardiol. 2008;102(12):1663–7. Derby CA, Feldman HA, Bausserman LL, Parker DR, Gans KM, Carleton RA. HDL cholesterol: trends in two southeastern New England communities, 1981–1993. Ann Epidemiol. 1998;8(2):84–91. Sprafka JM, Burke GL, Folsom AR, Luepker RV, Blackburn H. Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980–1982 and 1985–1987. Am J Epidemiol. 1990;132(3):489–500. Levine RL, Mosoni L, Berlett BS, Stadtman ER. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA. 1996;93(26):15036–40. Luo S, Levine RL. Methionine in proteins defends against oxidative stress. FASEB J. 2009;23(2):464–72. Gusdon AM, Votyakova TV, Mathews CE. mt-Nd2 suppresses reactive oxygen species production by mitochondrial complexes I and III. J Biol Chem. 2008;283(16):10690–7. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8–15. Okamura T. Dyslipidemia and cardiovascular disease: a series of epidemiologic studies in Japanese populations. J Epidemiol. 2010;20(4):259–65. Brousseau ME, Bodzioch M, Schaefer EJ, Goldkamp AL, Kielar D, Probst M, et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis. 2001;154(3):607–11.